How Gen Z Is Rewriting the Rules of Pharma M&A Strategy

In the Pharmaceutical Executive podcast episode "Gen-Z Influence on Pharma M&A," Ian Baer, Founder and Chief Soothsayer of Sooth, discusses how Gen Z's unique behaviors and preferences are impacting pharmaceutical mergers and acquisitions. Baer emphasizes that Gen Z's digital fluency, demand for authenticity, and value-driven decision-making are prompting pharma companies to rethink their strategies. He suggests that to effectively engage this generation, companies must prioritize transparency, leverage digital platforms, and align with causes that resonate with Gen Z's values. This shift is not only influencing marketing approaches but also shaping the broader strategic decisions within the pharmaceutical industry.

‍